A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study

Authors
Publication date
1 January 1994
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Brescia

    redirect
    oaioai:iris.unibs.it:11379/469232
    Last time updated on 07/09/2017